A 55-year-old woman who received the AstraZeneca vaccine against the coronavirus has been admitted to the Álvarez-Buylla hospital in Mieres (Asturias) due to a cerebral thrombosis.
According to El Comercio, the Asturian Ministry of Health is investigating whether this incident may be related to the administration of the vaccine, which has generated certain doubts due to the cases of venous thrombosis that it has caused in a few dozen people in the European Union after receive one of the AstraZeneca doses.
Citing Health sources, the information from El Comercio ensures that the patient is “stable” and with a good clinical evolution. At this time, the department is trying to find out if the thrombosis suffered by the patient bears similarities to those of the rest of the cases in Spain and Europe.
In mid-March, Spain and AstraZeneca stopped vaccination due to the appearance of different cases of venous thrombosis that caused several deaths. With the endorsement of the World Health Organization and the European Medicines Agency, .
However, doubts have persisted and, in the midst of a credibility crisis that has led to the company, the latest cases of death from clots in those vaccinated by AstraZeneca in the United Kingdom have not removed the uncertainty.
According to the first study on the cases of those vaccinated with AstraZeneca, the researchers have concluded that this type of thrombus resembles . In the absence of more detailed analysis, this would open the door to a treatment against this secondary effect of the vaccine.
Facebook Comments
Disqus